TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 3.955
AS - Asia 2.354
EU - Europa 1.874
SA - Sud America 476
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 71
OC - Oceania 4
Totale 8.890
Nazione #
US - Stati Uniti d'America 3.724
SG - Singapore 916
IT - Italia 599
CN - Cina 476
BR - Brasile 350
HK - Hong Kong 297
DE - Germania 278
RU - Federazione Russa 272
VN - Vietnam 257
IE - Irlanda 197
CA - Canada 169
SE - Svezia 128
BD - Bangladesh 80
GB - Regno Unito 79
FR - Francia 66
IN - India 57
FI - Finlandia 48
AT - Austria 42
AR - Argentina 39
KR - Corea 35
TR - Turchia 35
ES - Italia 30
MX - Messico 30
ZA - Sudafrica 30
NL - Olanda 29
PK - Pakistan 29
UA - Ucraina 29
JP - Giappone 26
ID - Indonesia 25
EC - Ecuador 23
PL - Polonia 22
IQ - Iraq 21
CO - Colombia 19
PH - Filippine 17
VE - Venezuela 15
CL - Cile 14
EG - Egitto 14
DK - Danimarca 13
SA - Arabia Saudita 11
MY - Malesia 10
JM - Giamaica 9
MA - Marocco 8
IL - Israele 7
UZ - Uzbekistan 7
IR - Iran 6
JO - Giordania 6
LT - Lituania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
PA - Panama 4
RO - Romania 4
SV - El Salvador 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DZ - Algeria 3
NI - Nicaragua 3
PE - Perù 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 8.728
Città #
Singapore 581
Ann Arbor 509
Ashburn 376
San Jose 351
Hong Kong 288
Chandler 196
Frankfurt am Main 195
Dublin 192
Woodbridge 168
Milan 148
Fairfield 129
Toronto 114
New York 105
Beijing 94
Dallas 91
Wilmington 91
Los Angeles 89
Ho Chi Minh City 81
The Dalles 67
Hanoi 64
Santa Clara 64
Council Bluffs 60
Houston 59
Hefei 58
Chicago 57
Seattle 53
Princeton 51
Shanghai 49
Phoenix 47
Rome 44
Cambridge 41
Jacksonville 41
São Paulo 38
Lissone 34
Moscow 34
Munich 33
Seoul 33
Boardman 32
Dearborn 30
Vienna 30
Lauterbourg 29
Buffalo 28
Altamura 24
Lawrence 23
Columbus 22
Brooklyn 20
Tokyo 20
London 18
Jakarta 17
Montreal 17
Nanjing 17
Turku 17
Warsaw 17
Helsinki 15
Johannesburg 14
Nuremberg 14
Orem 14
Washington 13
Lachine 12
Ottawa 12
Chennai 11
Da Nang 11
Denver 10
Rio de Janeiro 10
San Diego 10
Andover 9
Caronno Pertusella 9
Charlotte 9
Istanbul 9
Lahore 9
Mexico City 9
Turin 9
Alexandria 8
Atlanta 8
Bologna 8
Boston 8
Brasília 8
Guangzhou 8
Hangzhou 8
San Francisco 8
Xi'an 8
Baghdad 7
Belo Horizonte 7
Buenos Aires 7
Campinas 7
Changsha 7
Curitiba 7
Figino 7
Florence 7
Pavia 7
Quito 7
Shenyang 7
Stockholm 7
Tampa 7
Tashkent 7
Cape Town 6
Caracas 6
Coventry 6
Jinan 6
Karachi 6
Totale 5.495
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 401
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 370
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 340
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 325
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 316
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 315
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 308
Novel Therapies in Takayasu Arteritis 306
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 302
Neutrophil Extracellular Traps in the Autoimmunity Context 297
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 292
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 284
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 275
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 273
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 257
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 247
Immunology of membranous nephropathy: From animal models to humans 246
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 245
Evidence for charge-based mimicry in anti dsDNA antibody generation 242
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 231
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 228
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 225
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 224
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 221
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 219
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 207
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 203
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 203
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 199
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 196
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 188
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 187
ANCA-associated vasculitides (AAV) from the gender point of view 183
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 172
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 163
Totale 8.890
Categoria #
all - tutte 28.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20263.724 442 208 305 406 455 208 526 158 238 279 182 317
2026/2027543 135 171 237 0 0 0 0 0 0 0 0 0
Totale 8.890